HIGHLIGHTS
- who: Akifumi Matsuyama from the Center for reverse have published the research work: A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19, in the Journal: Scientific Reports Scientific Reports
- what: In this study, datasets for intention-to-treat (ITT) and safety analysis (SAF) were determined and analyzed.
- how: Because no placebos were available the study was conducted in an open-label. The saliva was tested for viral infectivity in a biosafety level 3 laboratory at the Osaka Habikino Medical Center.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.